Flavia Borellini is a prominent inventor based in Foster City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of assays for carcinogen detection and host cell DNA quantification. With a total of 2 patents, her work has the potential to impact cancer research and diagnostics.

Latest Patents

Borellini's latest patents include a quantitative assay of host cell DNA in a sample, which is designed to detect members of a conserved, dispersed gene family. This innovative method is used to ascertain levels of host cell genomic DNA in a sample. Another notable patent is her carcinogen assay, which focuses on methods and assays for the early determination of whether a test agent is a carcinogen. This invention correlates the pattern of differential gene expression from mammalian cells treated with the test agent with reference patterns from known carcinogens. Additionally, it includes methods for using DNA and RNA isolated from treated mammalian cells, as well as kits comprising these materials.

Career Highlights

Throughout her career, Flavia Borellini has worked with various companies, including Cell Genesys, Inc. Her expertise in biotechnology and innovative approaches to problem-solving have established her as a valuable contributor to the field.

Collaborations

Borellini has collaborated with notable professionals such as John M. Irving and David Jacobson-Kram. These partnerships have further enhanced her research and development efforts in the biotechnology sector.

Conclusion

Flavia Borellini's contributions to the field of biotechnology, particularly in carcinogen detection and host cell DNA assays, highlight her innovative spirit and dedication to advancing scientific knowledge. Her work continues to pave the way for future research and applications in cancer diagnostics.